Department of Electrocardiology, Institute of Cardiology, The John Paul II Hospital, School of Medicine, Jagiellonian University, Cracow, Poland.
Arch Med Sci. 2012 Dec 20;8(6):1027-34. doi: 10.5114/aoms.2012.28600. Epub 2012 May 13.
Thrombosis (VTh) is a rare dangerous complication of pacemaker implantation (PM). The aim of the study was to determine the dynamics of change in selected thrombotic and inflammatory factors after PM.
The study involved 81 patients (30 female, mean age: 71.1 years) with PM, divided into two groups. Group A (71 patients) consisted of patients without VTh, whereas group B (10 patients) comprised the patients with VTh. A transthoracic echocardiogram (TTE) and a venous ultrasound (VU) examination were performed. The levels of D-dimers, fibrinogen, tissue factor (TF), factor VII, plasminogen activator inhibitor-1 (PAI-1), interleukin-6 (IL-6) and high-sensitivity C-reactive protein (hsCRP) were determined in the venous blood. After PM, the TTE and VU examinations were repeated at 6 and 12 months, and blood analyses were performed within 7 days after PM, and subsequently at 6 and 12 months.
In 10 patients of group B, symptomatic VTh occurred at a mean time of 13.06 months after PM. Initially, the levels of IL-6, hsCRP, D-dimers, fibrinogen, TF, VII factor and PAI-1 were considerably higher in group B than in group A. In all patients the levels of these factors kept on increasing for up to 7 days after the procedure. In group A they subsequently decreased, whereas in group B they continued to rise.
Increased levels of inflammatory and thrombotic factors were observed in patients with VTh before and after PM. The factors of highest risk of VTh occurrence were D-dimers, fibrinogen and TF.
血栓形成(VTh)是心脏起搏器植入(PM)的罕见且危险的并发症。本研究旨在确定 PM 后选定的血栓形成和炎症因子的变化动态。
该研究纳入了 81 名(30 名女性,平均年龄:71.1 岁)PM 患者,分为两组。A 组(71 例)为无 VTh 的患者,B 组(10 例)为 VTh 患者。进行经胸超声心动图(TTE)和静脉超声(VU)检查。测定静脉血中的 D-二聚体、纤维蛋白原、组织因子(TF)、VII 因子、纤溶酶原激活物抑制剂-1(PAI-1)、白细胞介素-6(IL-6)和高敏 C 反应蛋白(hsCRP)水平。PM 后 6 个月和 12 个月重复 TTE 和 VU 检查,PM 后 7 天内及随后 6 个月和 12 个月进行血液分析。
B 组 10 例患者平均在 PM 后 13.06 个月出现有症状的 VTh。最初,B 组患者的 IL-6、hsCRP、D-二聚体、纤维蛋白原、TF、VII 因子和 PAI-1 水平明显高于 A 组。所有患者在手术后 7 天内这些因子水平持续升高。A 组患者的这些因子随后降低,而 B 组患者则继续升高。
VTh 患者在 PM 前后观察到炎症和血栓形成因子水平升高。D-二聚体、纤维蛋白原和 TF 是 VTh 发生的最高风险因素。